Updated on 9 June 2016
Australia-based medical technology company ImpediMed Limited has opened a regional office in Bloomington, Minnesota, and has also recruited two Minnesota medical technology veterans - Ann Holder and Jack Cosentino - to its executive leadership team.
According to Impedimed, these moves cap an eventful several months for the 55-person company, which develops products using bioimpedance spectroscopy (BIS) to measure, monitor and manage fluid status and body composition.
Among ImpediMed's 2016 developments: 1) The US commercial launch of its L-Dex system to aid in the clinical assessment of secondary unilateral lymphedema of the arm and leg in women and the leg in men; 2) The creation of a medical advisory board to counsel on the design of clinical trials for the use of its BIS technology in fluid detection for chronic heart failure patients; 3) The completion of a capital raising activity, which raised AU$75.1 million before costs; and 4) The signing of a five year, multi-location clinical trial agreement with Rochester, Minnesota-based Mayo Clinic.
ImpediMed's Minnesota office is positioned for growth as it will become the hub for the company's exploration of new clinical and home-based indications for its BIS technology. The company says that its US headquarters will remain at Carlsbad, California, with additional employees located at the corporate headquarters in Brisbane, Australia.
"Expanding to the Twin Cities will allow us to take advantage of the diverse and comprehensive medical technology, healthcare delivery and innovation ecosystem thriving across Minnesota," said Richard Carreon, CEO and Managing Director of ImpediMed. "When you factor in the availability of highly-skilled med-tech talent, quality of life for our employees and proximity to our clinical partners such as the Mayo Clinic, Minnesota is the perfect new home for growing our US operations."